In this part two series, participants give their opinions on the lasting effects of the pandemic. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next several days.
The pandemic flipped the switch on telehealth and at-home care, and the respondents to our annual Pharmacy Survey see them as having staying power. A quarter of the respondents said the increased use of telehealth will be the most important, lasting effect of the pandemic on the U.S. healthcare system and 35% put at-home care of all kinds in that category. Although many experts see the pandemic as accelerating the adoption of value-based payment, only 4% of our respondents ranked that as the pandemic’s most important lasting effect.
Not surprisingly, an increase in research and development on infectious disease got the most votes for the important, lasting effect on the pharmaceutical sector.
The online survey was conducted from April 5 through May 10.
Insights Into Chronic Itch From Shawn Kwatra, M.D.
April 15th 2025A Q&A between Shawn Kwatra, M.D., professor and chair of dermatology at the University of Maryland School of Medicine, and Managed Healthcare Executive about new discoveries in chronic itch, how treatment options are improving and the challenges patients face in getting access to the right therapies.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen